UBS AG Reaffirms Buy Rating for K2M Group Holdings, Inc. (KTWO)

UBS AG reaffirmed their buy rating on shares of K2M Group Holdings, Inc. (NASDAQ:KTWO) in a research report report published on Tuesday morning, www.benzinga.com reports. UBS AG currently has a $24.00 price objective on the medical device company’s stock, down from their prior price objective of $26.00.

Other equities analysts have also issued research reports about the company. Royal Bank Of Canada reissued a buy rating and set a $26.00 target price on shares of K2M Group Holdings in a research note on Thursday, July 20th. BidaskClub raised K2M Group Holdings from a hold rating to a buy rating in a research note on Wednesday, July 19th. Cowen and Company reissued a buy rating and set a $26.00 target price on shares of K2M Group Holdings in a research note on Wednesday, July 19th. Oppenheimer Holdings, Inc. reissued a buy rating on shares of K2M Group Holdings in a research note on Tuesday, July 11th. Finally, Piper Jaffray Companies reissued a buy rating and set a $28.00 target price on shares of K2M Group Holdings in a research note on Thursday, September 28th. One analyst has rated the stock with a sell rating, one has given a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. K2M Group Holdings currently has an average rating of Buy and a consensus target price of $25.60.

K2M Group Holdings (NASDAQ:KTWO) last posted its earnings results on Tuesday, August 1st. The medical device company reported ($0.21) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.22) by $0.01. K2M Group Holdings had a negative return on equity of 15.45% and a negative net margin of 16.21%. The firm had revenue of $65.70 million for the quarter, compared to analyst estimates of $66.26 million. During the same quarter in the prior year, the company earned ($0.27) EPS. K2M Group Holdings’s revenue was up 11.0% on a year-over-year basis.

TRADEMARK VIOLATION NOTICE: This news story was published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this news story can be read at https://www.tickerreport.com/banking-finance/2958173/ubs-ag-reaffirms-buy-rating-for-k2m-group-holdings-inc-ktwo.html.

In other K2M Group Holdings news, CFO Gregory S. Cole sold 2,350 shares of the stock in a transaction dated Tuesday, August 15th. The stock was sold at an average price of $24.08, for a total value of $56,588.00. Following the sale, the chief financial officer now owns 55,158 shares of the company’s stock, valued at approximately $1,328,204.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider John Philip Md Kostuik sold 1,090 shares of the stock in a transaction dated Tuesday, August 15th. The shares were sold at an average price of $24.08, for a total value of $26,247.20. Following the completion of the sale, the insider now directly owns 201,961 shares in the company, valued at approximately $4,863,220.88. The disclosure for this sale can be found here. Insiders sold a total of 44,129 shares of company stock worth $1,033,644 in the last ninety days. 5.80% of the stock is owned by corporate insiders.

A number of hedge funds have recently bought and sold shares of the business. Paulson & CO. Inc. raised its position in K2M Group Holdings by 13.6% in the 2nd quarter. Paulson & CO. Inc. now owns 109,600 shares of the medical device company’s stock valued at $2,670,000 after purchasing an additional 13,100 shares in the last quarter. California State Teachers Retirement System raised its position in K2M Group Holdings by 41.8% in the 2nd quarter. California State Teachers Retirement System now owns 71,871 shares of the medical device company’s stock valued at $1,751,000 after purchasing an additional 21,200 shares in the last quarter. The Manufacturers Life Insurance Company raised its position in K2M Group Holdings by 51.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 31,807 shares of the medical device company’s stock valued at $774,000 after purchasing an additional 10,738 shares in the last quarter. State Street Corp raised its position in K2M Group Holdings by 39.8% in the 2nd quarter. State Street Corp now owns 713,257 shares of the medical device company’s stock valued at $17,378,000 after purchasing an additional 203,067 shares in the last quarter. Finally, Macquarie Group Ltd. raised its position in K2M Group Holdings by 0.3% in the 2nd quarter. Macquarie Group Ltd. now owns 200,656 shares of the medical device company’s stock valued at $4,888,000 after purchasing an additional 581 shares in the last quarter. 97.86% of the stock is currently owned by institutional investors.

K2M Group Holdings Company Profile

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Analyst Recommendations for K2M Group Holdings (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.